{"transactions":[{"id":4615777,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615776,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.44,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615775,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":3100,"price":68.088,"value":211072.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $68.088, and the range of prices were between $67.94 and $68.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":91500,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615774,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":14000,"price":67.4634,"value":944487.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $67.4634, and the range of prices were between $66.93 and $67.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":94600,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615773,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":66.15,"value":79380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $66.15, and the range of prices were between $65.93 and $66.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":108600,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615772,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":65.3917,"value":111165.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $65.3917, and the range of prices were between $64.835 and $65.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":109800,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615771,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":26.52,"value":265200.0,"ownership":{"direct":true},"balance_after":111500,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":4615770,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:05:18.000Z","date":"2026-09-10","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":17.44,"value":174400.0,"ownership":{"direct":true},"balance_after":101500,"source":{"system":"sec-edgar","filing":"0001506916-26-000004","document":"form4-09112026_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000150691626000004/form4-09112026_040911.xml","form_type":"4"}},{"id":767808,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-21T21:00:17.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12000,"derivative":{"exercise_price":42.26,"exercise_date":"2027-05-19","expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001506916-26-000003","document":"form4-05212026_050510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000150691626000003/form4-05212026_050510.xml","form_type":"4"}},{"id":767807,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T21:00:17.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":91500,"source":{"system":"sec-edgar","filing":"0001506916-26-000003","document":"form4-05212026_050510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000150691626000003/form4-05212026_050510.xml","form_type":"4"}},{"id":789867,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-07T00:00:33.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.33,"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001506916-26-000001","document":"form4-05062026_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000150691626000001/form4-05062026_080516.xml","form_type":"4"}},{"id":789866,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T00:00:33.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":45,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 17, 2025 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person on May 18, 2016 with an expiration date of May 18, 2026."}],"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001506916-26-000001","document":"form4-05062026_080516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000150691626000001/form4-05062026_080516.xml","form_type":"4"}},{"id":789865,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T00:00:33.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":16.33,"value":130640.0,"ownership":{"direct":true},"balance_after":95500,"source":{"system":"sec-edgar","filing":"0001506916-26-000001","document":"form4-05062026_080516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000150691626000001/form4-05062026_080516.xml","form_type":"4"}},{"id":904814,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":12136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":12136,"derivative":{"exercise_price":1.75,"exercise_date":"2026-02-11","expiration_date":"2030-07-27","underlying":"Common Stock","underlying_shares":12136},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":904813,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":0,"derivative":{"exercise_price":8.3,"exercise_date":"2025-07-27","expiration_date":"2030-07-27","underlying":"Common Stock","underlying_shares":12136},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":904812,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":1519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":1519,"derivative":{"exercise_price":1.75,"exercise_date":"2026-02-11","expiration_date":"2029-11-25","underlying":"Common Stock","underlying_shares":1519},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":904811,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":0,"derivative":{"exercise_price":29.4,"exercise_date":"2024-11-25","expiration_date":"2029-11-25","underlying":"Common Stock","underlying_shares":1519},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":904810,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":3033,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":3033,"derivative":{"exercise_price":1.75,"exercise_date":"2026-02-11","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":3033},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":904809,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2026-02-13T21:15:18.000Z","date":"2026-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3033,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective February 11, 2026, the Board of Directors of the Company approved a unilateral reduction in the per share exercise price of the warrants to $1.75. All of the other terms of the warrants remained unchanged."}],"balance_after":0,"derivative":{"exercise_price":47.6,"exercise_date":"2024-08-08","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":3033},"source":{"system":"sec-edgar","filing":"0001493152-26-006707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315226006707/ownership.xml","form_type":"4"}},{"id":957978,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:01:21.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":216617,"price":2.03,"value":439732.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired 216,617 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025."}],"balance_after":229929,"source":{"system":"sec-edgar","filing":"0001493152-25-029355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315225029355/ownership.xml","form_type":"4"}},{"id":1079654,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrants","published_at":"2025-07-29T20:15:27.000Z","date":"2025-07-27","kind":"grant","planned":false,"acquired":true,"shares":12136,"price":8.3024,"value":100757.9264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025."}],"balance_after":16688,"derivative":{"exercise_price":8.3024,"exercise_date":"2025-07-27","expiration_date":"2030-07-27","underlying":"Common Stock","underlying_shares":12136},"source":{"system":"sec-edgar","filing":"0001641172-25-021376","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225021376/ownership.xml","form_type":"4"}},{"id":1079653,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-29T20:15:27.000Z","date":"2025-07-27","kind":"grant","planned":false,"acquired":true,"shares":6068,"price":8.3024,"value":50378.9632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025."}],"balance_after":13312,"source":{"system":"sec-edgar","filing":"0001641172-25-021376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225021376/ownership.xml","form_type":"4"}},{"id":1145194,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-05-16T23:00:14.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":21.15,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-25-013500","document":"form4-05162025_070511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013500/form4-05162025_070511.xml","form_type":"4"}},{"id":1145193,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T23:00:14.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001415889-25-013500","document":"form4-05162025_070511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013500/form4-05162025_070511.xml","form_type":"4"}},{"id":1173186,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0.037,"value":46.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":355.2,"exercise_date":"2018-06-28","expiration_date":"2025-06-28","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1173185,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1563,"price":0.037,"value":57.831,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":611.2,"exercise_date":"2019-04-04","expiration_date":"2026-04-04","underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1173184,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"sStock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"price":0.037,"value":55.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":425.6,"exercise_date":"2017-04-10","expiration_date":"2027-04-10","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1173183,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":813,"price":0.037,"value":30.081,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":425.6,"exercise_date":"2017-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":813},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1173182,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3750,"price":0.037,"value":138.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":24.6,"exercise_date":"2020-07-15","expiration_date":"2027-07-15","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1173181,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T20:15:21.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4750,"price":0.037,"value":175.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":536,"exercise_date":"2017-12-11","expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001641172-25-003824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000164117225003824/ownership.xml","form_type":"4"}},{"id":1350668,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock Warrants","published_at":"2024-11-26T21:12:39.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":42553,"price":1.175,"value":49999.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78."}],"balance_after":42553,"derivative":{"exercise_price":1.05,"expiration_date":"2029-11-25","underlying":"Common Stock","underlying_shares":42553},"source":{"system":"sec-edgar","filing":"0001493152-24-047808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224047808/ownership.xml","form_type":"4"}},{"id":1350667,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2024-11-26T21:12:39.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":42553,"price":1.175,"value":49999.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78."}],"balance_after":202859,"source":{"system":"sec-edgar","filing":"0001493152-24-047808","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224047808/ownership.xml","form_type":"4"}},{"id":1388029,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T20:05:09.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.105,"expiration_date":"2034-10-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-040726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224040726/ownership.xml","form_type":"4"}},{"id":1397855,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-10-01T00:38:12.000Z","date":"2024-09-30","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.48,"expiration_date":"2024-10-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-024117","document":"form4-10012024_121008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924024117/form4-10012024_121008.xml","form_type":"4"}},{"id":1397854,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-01T00:38:12.000Z","date":"2024-09-30","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":14.0581,"value":562324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on March 15, 2024 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person on October 8, 2014 with an expiration date of October 8, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $14.0581, and the range of prices were between $13.782 and $14.40.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001415889-24-024117","document":"form4-10012024_121008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924024117/form4-10012024_121008.xml","form_type":"4"}},{"id":1397853,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-01T00:38:12.000Z","date":"2024-09-30","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":10.48,"value":419200.0,"ownership":{"direct":true},"balance_after":121000,"source":{"system":"sec-edgar","filing":"0001415889-24-024117","document":"form4-10012024_121008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924024117/form4-10012024_121008.xml","form_type":"4"}},{"id":1437729,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock Warrants","published_at":"2024-08-08T21:30:46.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":true,"shares":84932,"price":1.825,"value":155000.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90."}],"balance_after":84932,"derivative":{"exercise_price":1.7,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":84932},"source":{"system":"sec-edgar","filing":"0001493152-24-030839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224030839/ownership.xml","form_type":"4"}},{"id":1437728,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2024-08-08T21:30:46.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":true,"shares":84932,"price":1.825,"value":155000.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90."}],"balance_after":160306,"source":{"system":"sec-edgar","filing":"0001493152-24-030839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224030839/ownership.xml","form_type":"4"}},{"id":1520562,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-10T20:05:48.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":6.82,"exercise_date":"2025-05-08","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-24-012848","document":"form4-05102024_040536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012848/form4-05102024_040536.xml","form_type":"4"}},{"id":1520561,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:05:48.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001415889-24-012848","document":"form4-05102024_040536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012848/form4-05102024_040536.xml","form_type":"4"}},{"id":1672752,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T21:15:44.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-003450","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315224003450/ownership.xml","form_type":"4"}},{"id":1884444,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-19T20:05:43.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":13500,"derivative":{"exercise_price":17.11,"exercise_date":"2024-05-17","expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-23-030961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030961/doc4.xml","form_type":"4"}},{"id":1884443,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:05:43.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":74500,"source":{"system":"sec-edgar","filing":"0001209191-23-030961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030961/doc4.xml","form_type":"4"}},{"id":2049433,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T21:05:55.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026."}],"balance_after":100000,"derivative":{"exercise_price":1.61,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-002021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315223002021/ownership.xml","form_type":"4"}},{"id":2106572,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-11-22T13:00:13.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":9600,"price":1.9,"value":18240.0,"ownership":{"direct":true},"balance_after":75374,"source":{"system":"sec-edgar","filing":"0001493152-22-033241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222033241/ownership.xml","form_type":"4"}},{"id":2106571,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-11-22T13:00:13.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":400,"price":1.7637,"value":705.48,"ownership":{"direct":true},"balance_after":65774,"source":{"system":"sec-edgar","filing":"0001493152-22-033241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222033241/ownership.xml","form_type":"4"}},{"id":2161037,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-09-12T13:00:19.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":10308,"price":2.8,"value":28862.4,"ownership":{"direct":true},"balance_after":65374,"source":{"system":"sec-edgar","filing":"0001493152-22-025578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222025578/ownership.xml","form_type":"4"}},{"id":2162917,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-09-08T13:00:30.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":8632,"price":2.57,"value":22184.24,"ownership":{"direct":true},"balance_after":55066,"source":{"system":"sec-edgar","filing":"0001493152-22-025319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222025319/ownership.xml","form_type":"4"}},{"id":2162916,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-09-08T13:00:30.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":1060,"price":2.44,"value":2586.4,"ownership":{"direct":true},"balance_after":46434,"source":{"system":"sec-edgar","filing":"0001493152-22-025319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222025319/ownership.xml","form_type":"4"}},{"id":2239960,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common stock","published_at":"2022-06-07T12:00:38.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":19727,"price":2.63,"value":51882.01,"ownership":{"direct":true},"balance_after":45374,"source":{"system":"sec-edgar","filing":"0001493152-22-016027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222016027/ownership.xml","form_type":"4"}},{"id":2273414,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-13T00:26:35.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":21.38,"exercise_date":"2023-05-11","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-028697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028697/doc4.xml","form_type":"4"}},{"id":2273413,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:26:35.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001209191-22-028697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028697/doc4.xml","form_type":"4"}},{"id":2422289,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:30:59.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":200000,"derivative":{"exercise_price":4.9,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-22-002554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315222002554/ownership.xml","form_type":"4"}},{"id":2502328,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2021-11-19T14:16:29.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":11187,"price":5.82,"value":65108.34,"ownership":{"direct":true},"balance_after":25647,"source":{"system":"sec-edgar","filing":"0001493152-21-029297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315221029297/ownership.xml","form_type":"4"}},{"id":2567380,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2021-09-16T22:22:00.000Z","date":"2021-09-14","kind":"purchase","acquired":true,"shares":12000,"price":7,"value":84000.0,"ownership":{"direct":true},"balance_after":14460,"source":{"system":"sec-edgar","filing":"0001493152-21-022936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315221022936/ownership.xml","form_type":"4"}},{"id":2611193,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-06T21:00:52.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":375000,"derivative":{"exercise_price":8.87,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001493152-21-018910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000149315221018910/ownership.xml","form_type":"4"}},{"id":2707794,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-19T01:19:18.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":18.27,"exercise_date":"2022-05-14","expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-033849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121033849/doc4.xml","form_type":"4"}},{"id":2707793,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T01:19:18.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":67000,"source":{"system":"sec-edgar","filing":"0001209191-21-033849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121033849/doc4.xml","form_type":"4"}},{"id":3080155,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T20:38:28.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023."}],"balance_after":300000,"derivative":{"exercise_price":0.3075,"expiration_date":"2027-07-15","underlying":"Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-20-017812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000121390020017812/ownership.xml","form_type":"4"}},{"id":3142536,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2020-05-20T00:00:19.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":15.43,"exercise_date":"2021-05-15","expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-030748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919120030748/doc4.xml","form_type":"4"}},{"id":3142535,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T00:00:19.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64000,"source":{"system":"sec-edgar","filing":"0001209191-20-030748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919120030748/doc4.xml","form_type":"4"}},{"id":3426550,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-29T20:16:31.000Z","date":"2019-08-28","kind":"purchase","acquired":true,"shares":20000,"price":0.681,"value":13620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.66 to $0.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":196761,"source":{"system":"sec-edgar","filing":"0001213900-19-016939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000121390019016939/ownership.xml","form_type":"4"}},{"id":3428149,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-27T20:18:31.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":100000,"price":0.457,"value":45700.0,"ownership":{"direct":true},"balance_after":176761,"source":{"system":"sec-edgar","filing":"0001213900-19-016791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000121390019016791/ownership.xml","form_type":"4"}},{"id":3531434,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2019-05-11T00:37:07.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":17.94,"exercise_date":"2020-05-08","expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-029156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029156/doc4.xml","form_type":"4"}},{"id":3531433,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-11T00:37:07.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61000,"source":{"system":"sec-edgar","filing":"0001209191-19-029156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029156/doc4.xml","form_type":"4"}},{"id":3561130,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-05T21:27:22.000Z","date":"2019-04-04","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on April 4, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through April 4, 2022."}],"balance_after":125000,"derivative":{"exercise_price":7.64,"expiration_date":"2026-04-04","underlying":"Ordinary Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-19-005894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506916/000121390019005894/ownership.xml","form_type":"4"}},{"id":3936944,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-12T01:06:45.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-029720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919118029720/doc4.xml","form_type":"4"}},{"id":3936943,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-12T01:06:45.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-18-029720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919118029720/doc4.xml","form_type":"4"}},{"id":4313497,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-18T22:19:07.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":17.44,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-033722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919117033722/doc4.xml","form_type":"4"}},{"id":4313496,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45204,"kind":"person","name":"Meckler Jeffrey A","position":1,"cik":"0001506916","reported_name":"Meckler Jeffrey A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-18T22:19:07.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56500,"source":{"system":"sec-edgar","filing":"0001209191-17-033722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919117033722/doc4.xml","form_type":"4"}}]}